This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
ADSTILADRIN
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
ECLIPSE
ESCAPE
FORT
NRG-GU 0101
Masofaniten (EPI-7386)
METANOVA
RTIRE
SHORTER
Right Side
PCCTC
DORA
IRONMAN
PROMISE
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Petros Grivas, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SESAUA 2024
Southern CA GU Cancer Research Forum 2024
AUA Urology Advocacy Summit 2024
ASCO GU 2024
2024 UCSF-UCLA PSMA Conference
SUO 2023
All Conferences
View All
PCF
UroToday Home
Available Urotoday Newsletters - Site Registration Required
Prostate Cancer Daily
Go
Reset
Send Date
Subject
Created Date
ID
Asc
Desc
Prostate Cancer Daily
Sent on 28 March 2024
Receive via e-mail
PARP Inhibitors: Targeting DNA Repair Pathways
Sent on 28 March 2024
Receive via e-mail
Prostate Cancer Daily
Sent on 27 March 2024
Receive via e-mail
Prostate Cancer Daily
Sent on 26 March 2024
Receive via e-mail
Southeastern Section of the AUA Highlights in Prostate Cancer
Sent on 26 March 2024
Receive via e-mail
Prostate Cancer Daily
Sent on 25 March 2024
Receive via e-mail
Prostate Cancer Daily
Sent on 22 March 2024
Receive via e-mail
Staging and Treatment Planning with PSMA Molecular Imaging
Sent on 22 March 2024
Receive via e-mail
Prostate Cancer Daily
Sent on 21 March 2024
Receive via e-mail
Prostate Cancer Daily
Sent on 20 March 2024
Receive via e-mail
Prostate Cancer Daily
Sent on 19 March 2024
Receive via e-mail
Research and Innovation Leading to New Targets for Theranostics in Prostate Cancer
Sent on 19 March 2024
Receive via e-mail
Prostate Cancer Daily
Sent on 18 March 2024
Receive via e-mail
Prostate Cancer Daily
Sent on 15 March 2024
Receive via e-mail
Prostate Cancer Daily
Sent on 14 March 2024
Receive via e-mail
Collaborative Workflow Sharing Among Clinicians for Patients with Prostate Cancer
Sent on 14 March 2024
Receive via e-mail
Prostate Cancer Daily
Sent on 13 March 2024
Receive via e-mail
Prostate Cancer Daily
Sent on 12 March 2024
Receive via e-mail
Clinical Trials Enhancing Clinical Choices for PSMA Imaging and Therapy Selection
Sent on 12 March 2024
Receive via e-mail
Prostate Cancer Daily
Sent on 11 March 2024
Receive via e-mail
Prostate Cancer Daily
Sent on 08 March 2024
Receive via e-mail
International Women's Day 2024: Celebrating the Diverse Contributions of Women in Science
Sent on 08 March 2024
Receive via e-mail
Prostate Cancer Daily
Sent on 07 March 2024
Receive via e-mail
Prostate Cancer Daily
Sent on 06 March 2024
Receive via e-mail
Prostate Cancer Daily
Sent on 05 March 2024
Receive via e-mail
Collaboration in Managing mCRPC Patients Including Triplet Therapy Integration
Sent on 05 March 2024
Receive via e-mail
Prostate Cancer Daily
Sent on 04 March 2024
Receive via e-mail
Prostate Cancer Foundation's Guidelines for Black Men in the United States
Sent on 02 March 2024
Receive via e-mail
Prostate Cancer Daily
Sent on 01 March 2024
Receive via e-mail
Transforming Healthcare Policy: Challenges, Strategies, and Advocacy Priorities
Sent on 01 March 2024
Receive via e-mail
Prostate Cancer Daily
Sent on 29 February 2024
Receive via e-mail
The Heterogeneity of Prostate Cancer Prompts a Shift Towards a Targeted Treatment Approach
Sent on 29 February 2024
Receive via e-mail
Prostate Cancer Daily
Sent on 28 February 2024
Receive via e-mail
Advances in PSMA Theranostics: From Diagnosis to Treatment in Prostate Cancer
Sent on 28 February 2024
Receive via e-mail
Prostate Cancer Daily
Sent on 27 February 2024
Receive via e-mail
Prostate Cancer Daily
Sent on 26 February 2024
Receive via e-mail
Design, Access and Consensus Criteria in GU Clinical Trials
Sent on 24 February 2024
Receive via e-mail
Prostate Cancer Daily
Sent on 23 February 2024
Receive via e-mail
Managing Nonmetastatic CRPC: Imaging, Treatment Options, and Provider Collaboration
Sent on 23 February 2024
Receive via e-mail
Prostate Cancer Daily
Sent on 22 February 2024
Receive via e-mail
Prostate Cancer Daily
Sent on 21 February 2024
Receive via e-mail
Prostate Cancer Daily
Sent on 20 February 2024
Receive via e-mail
Prostate Cancer Daily
Sent on 19 February 2024
Receive via e-mail
Prostate Cancer Daily
Sent on 16 February 2024
Receive via e-mail
Challenging Androgen Resistance in Prostate Cancer with Novel Approaches
Sent on 16 February 2024
Receive via e-mail
Prostate Cancer Daily
Sent on 15 February 2024
Receive via e-mail
Learning from the Experts: Exploring New Pathways Beyond Androgen Blockade for Treating mCRPC and mHSPC
Sent on 15 February 2024
Receive via e-mail
Prostate Cancer Daily
Sent on 14 February 2024
Receive via e-mail
Understanding the Biological Basis of mCRPC Leads to Novel Approaches to Management
Sent on 14 February 2024
Receive via e-mail
Prostate Cancer Daily
Sent on 13 February 2024
Receive via e-mail
Page
of 87
Display #
5
10
15
20
25
30
50
100
Results 1 - 50 out of 4335
Send the selected Newsletters to...
Name
E-mail
Send
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free